Market Exclusive

Applied Genetic Technologies Corp (NASDAQ:AGTC) gets upgraded to Outperform by BMO Capital Markets with a price target of $9.00

Analyst Ratings For Applied Genetic Technologies Corp (NASDAQ:AGTC)

Today, Applied Genetic Technologies Corp (NASDAQ:AGTC) stock received an upgrade by BMO Capital Markets from Market Perform to Outperform with a price target of $9.00.

There are 6 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.

The current consensus rating on Applied Genetic Technologies Corp (NASDAQ:AGTC) is Buy with a consensus target price of $12.25 per share, a potential 206.25% upside.

Some recent analyst ratings include

Recent Trading Activity for Applied Genetic Technologies Corp (NASDAQ:AGTC)
Shares of Applied Genetic Technologies Corp closed the previous trading session at 4.00 up +0.22 5.82% with 3.7 shares trading hands.

Exit mobile version